Violeta Dejanira Álvarez Jiménez

Violeta Dejanira Álvarez Jiménez

Auto-generated profile, based on publicly available information

Violeta Dejanira Álvarez Jiménez

Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
VAVioleta D. Alvarez-Jiménez
Violeta D. Alvarez-Jiménez
KLKahiry Leyva-Paredes
Kahiry Leyva-Paredes
MGMariano García-Martínez
Mariano García-Martínez
LVLuis Vázquez-Flores
Luis Vázquez-Flores
VGVíctor Gabriel García-Paredes
Víctor Gabriel García-Paredes
IEIris Estrada-García
Iris Estrada-García
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (Mtb). In the lungs, macrophages and neutrophils are the first immune cells that have contact with the infecting mycobacteria. Neutrophils are phagocytic cells that kill microorganisms through several mechanisms, which include the lytic enzymes and antimicrobial peptides that are found in their lysosomes, and the production of reactive oxygen species. Neutrophils also release extracellular vesicles (EVs) (100–1,000 nm in diameter) to the extracellular milieu; these EVs consist of a lipid bilayer surrounding a hydrophilic core and participate in intercellular communication. We previously demonstrated that human neutrophils infected in vitro with Mtb H37Rv release EVs (EV-TB), but the effect of these EVs on other cells relevant for the control of Mtb infection, such as macrophages, has not been completely analyzed. In this study, we characterized the EVs produced by non-stimulated human neutrophils (EV-NS), and the EVs produced by neutrophils stimulated with an activator (PMA), a peptide derived from bacterial proteins (fMLF) or Mtb, and observed that the four EVs differed in their size. Ligands for toll-like receptor (TLR) 2/6 were detected in EV-TB, and these EVs favored a modest increase in the expression of the co-stimulatory molecules CD80, a higher expression of CD86, and the production of higher amounts of TNF-α and IL-6, and of lower amounts of TGF-β, in autologous human macrophages, compared with the other EVs. EV-TB reduced the amount of intracellular Mtb in macrophages, and increased superoxide anion production in these cells. TLR2/6 ligation and superoxide anion production are known inducers of autophagy; accordingly, we found that EV-TB induced higher expression of the autophagy-related marker LC3-II in macrophages, and the co-localization of LC3-II with Mtb inside infected macrophages. The intracellular mycobacterial load increased when autophagy was inhibited with wortmannin in these cells. In conclusion, our results demonstrate that neutrophils produce different EVs in response to diverse activators, and that EV-TB activate macrophages and promote the clearance of intracellular Mtb through early superoxide anion production and autophagy induction, which is a novel role for neutrophil-derived EVs in the immune response to Mtb.

1 August 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MGMariano Garcia-Martinez
Mariano Garcia-Martinez
LVLuis Vázquez-Flores
Luis Vázquez-Flores
VAVioleta D. Alvarez-Jiménez
Violeta D. Alvarez-Jiménez
JCJessica Castañeda-Casimiro
Jessica Castañeda-Casimiro
MIMiguel Ibañez-Hernandez
Miguel Ibañez-Hernandez
IEIris Estrada-Garcia
Iris Estrada-Garcia
Background: Tuberculosis is the leading cause of death by an infectious microorganism worldwide. Conventional treatment lasts at least six months and has adverse effects; therefore, it is important to find therapeutic alternatives that reduce the bacterial load and may reduce the treatment duration. The immune response against tuberculosis can be modulated by several mechanisms, including extracellular vesicles (EVs), which are nano-sized membrane-bound structures that constitute an efficient communication mechanism among immune cells. Methods: The EVs released by the J774A.1 mouse macrophage cell line, both spontaneously (S-EV) and after infection with Mycobacterium tuberculosis H37Rv (Mtb-EV), were purified by ultra-centrifugation and size-exclusion chromatography. The size distribution and chemical composition of these EVs were evaluated, and their effect on the bacterial load and the production of cytokines was determined in both in vitro and in vivo models of M. tuberculosis infection. Results: Mtb-EV are larger than S-EV, they contain M. tuberculosis-specific antigens (not detected in EVs released from M. fortuitum-infected J774A.1 cells) and are rich in phosphatidylserine, present in their outer membrane layer. S-EV, but not Mtb-EV, reduced the bacterial load and the production of MCP-1 and TNF-α in M. tuberculosis-infected macrophages, and these effects were reversed when phosphatidylserine was blocked with annexin V. Both S-EV and Mtb-EV significantly reduced the lung bacterial load in mice infected with M. tuberculosis after 60 days of treatment, but they had no effect on survival or on the lung pneumonic area of these mice. Conclusion: J774A.1 macrophages infected with M. tuberculosis H37Rv released EVs that differed in size and phosphatidylserine content from spontaneously released EVs, and these EVs also had different biological effects: S-EV reduced the mycobacterial load and the cytokine production in vitro (through a phosphatidylserine-dependent mechanism), while both EVs reduced the lung bacterial load in vivo. These results are the basis for further experiments to evaluate whether EVs improve the efficiency of the conventional treatment for tuberculosis.

1 June 2014 in Natural Product Communications
Verified
Journal Article
Open access
PDF file
UGUriel García-Hernández
Uriel García-Hernández
FRFrank H Robledo-Avila
Frank H Robledo-Avila
VÁVioleta D. Álvarez-Jiménez
Violeta D. Álvarez-Jiménez
OROctavio Rodríguez-Cortés
Octavio Rodríguez-Cortés
IWIsabel Wong-Baeza
Isabel Wong-Baeza
RCRommel Chacon-Salinas
Rommel Chacon-Salinas
Dialyzable leukocyte extracts (DLE) transfer specific cell-mediated immune responses from sensitized donors to non-immune recipients. In addition, DLE have several immunomodulatory effects and are used for the treatment of several infectious and non-infectious diseases. Previous studies showed that human DLE obtained from virus-infected leukocytes and bovine DLE decrease the production of the pro-inflammatory cytokine TNF-α in response to bacterial lipopolysaccharide, in vitro and in vivo. In the present work, we inquire as to whether DLE from uninfected human leukocytes have the ability to regulate cytokine production in peripheral blood mononuclear cells (PBMC) in vitro. We observed that PBMC from healthy individuals were able to produce TNF-α, IL-12 and IL-10 after stimulation with DLE. Moreover, we identified monocytes as the main cell population that produced TNF-α after DLE stimulation. Interestingly, we found that DLE contain unidentified ligands that activate Toll-like receptor (TLR)-2. Finally, we observed that DLE directly activated monocytes through TLR-2. These results reveal a new biological activity of DLE, and suggest that part of the immunomodulatory properties of DLE could be attributed to TLR-2 activation on monocytes and to the induction of a pro-inflammatory environment that is crucial for control of infectious diseases.

29 January 2024 in Ciencia Latina Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
DCDulce Yesenia Martínez de la Cruz
Dulce Yesenia Martínez de la Cruz
GRGuadalupe Rojas Ramírez
Guadalupe Rojas Ramírez
FCFélix Guillermo Márquez Celedonio
Félix Guillermo Márquez Celedonio
VJVioleta Dejanira Álvarez Jiménez
Violeta Dejanira Álvarez Jiménez
MMMiriam Cortez Mercado
Miriam Cortez Mercado
Las medidas de bioseguridad son el conjunto de principios y técnicas para impedir la exposición accidental a toxinas o agentes biológicos promotores de riesgos a la salud. Se realizó estudio en personal de enfermería quirúrgica de un hospital de tercer nivel de atención para determinar la correlación del nivel de conocimiento sobre medidas de bioseguridad con su cumplimiento. Se aplicaron instrumento validado para evaluar nivel de conocimientos y lista de cotejo de indicadores de bioseguridad para determinar su cumplimiento; el análisis estadístico incluyó prueba de correlación de Pearson, Chi cuadrada, t de Student y U de Mann-Whitney. Se incluyeron 55 individuos con edad de 36.9 ± 5.5 años, 29 (52.7%) categoría de especialistas y 5.6 ± 5.6 años de antigüedad en área quirúrgica. Nivel de conocimiento fue alto en 43 (78.2%) y el de cumplimiento bajo o insuficiente en 44 (80.0%). No hubo diferencias estadísticamente significativas en variables sociodemográficas y laborales entre los grupos con alto y bajo cumplimiento (p > 0.05) y la correlación entre conocimiento y cumplimiento fue rs = 0.117. Se concluye que el personal de enfermería quirúrgica tiene nivel de conocimiento sobre medidas de bioseguridad alto y nivel de cumplimiento bajo con correlación positiva débil.